• Accueil >
  • Publications >
  • Impact of follow-up on generalized pairwise comparisons for estimating the irinotecan benefit in advanced/metastatic gastric cancer

Impact of follow-up on generalized pairwise comparisons for estimating the irinotecan benefit in advanced/metastatic gastric cancer

1 juin 2021Contemporary Clinical Trials

DOI : 10.1016/j.cct.2021.106400

Auteurs

Ali N. Chamseddine, Koji Oba, Marc Buyse, Narikazu Boku, Olivier Bouché, Tuvana Satar, Anne Auperin, Xavier Paoletti